Ticagrelor IP 90 mg Tablets are an effective antiplatelet medicine designed to reduce the risk of harmful blood clots in patients at risk of cardiovascular events. Ticagrelor belongs to the class of blood thinners that work by preventing platelets in the blood from clumping together, thereby maintaining smooth blood flow and protecting the heart and blood vessels. Manufactured under strict quality standards, these tablets are suitable for patients requiring clinical management of heart conditions such as acute coronary syndrome or after stent placement.
Ticagrelor IP (90 mg): An antiplatelet agent that inhibits platelet aggregation, reducing the formation of harmful clots in arteries and helping prevent heart attacks, strokes, and other cardiovascular complications.
Take Ticagrelor 90 mg Tablets exactly as prescribed by your doctor. Swallow the tablet whole with water. Do not change your dose or stop therapy without medical advice. Regular check-ups and monitoring are recommended.
Some patients may experience mild bleeding, nosebleeds, bruising, or dizziness. Consult your doctor if side effects persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Ticagrelor IP 90 mg sourced from reputed pharmaceutical manufacturers. Tikadec 90 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.